Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.

Grem JL, Geoffroy F, Politi PM, Cuddy DP, Ross DD, Nguyen D, Steinberg SM, Allegra CJ.

Mol Pharmacol. 1995 Aug;48(2):305-15.

PMID:
7651364
2.
3.
4.

Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-beta-D-arabinofuranosylcytosine.

Ross DD, Cuddy DP, Cohen N, Hensley DR.

Cancer Chemother Pharmacol. 1992;31(1):61-70.

PMID:
1458561
5.

Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs.

de Valeriola DL, Ross DD, Forrest A, Cuddy DP, Egorin MJ.

Cancer Chemother Pharmacol. 1991;29(2):133-40.

PMID:
1760856
6.

Supplemental Content

Loading ...
Support Center